Explores how supplement formats impact adherence and how oral thin films aim to improve consistency and usability.
Walk into any pharmacy today and the supplements aisle looks impressive. Hundreds of products, colorful labels, claims about absorption rates and bioavailability. Companies have invested millions in branding, in sourcing, in clinical testing. The science behind what goes into a capsule has genuinely improved over the decades.
But the capsule itself? Still a capsule.
That’s the contradiction sitting at the center of a $150 billion global industry. The formulas have evolved. The formats have not. And for a growing number of clinicians and researchers, that gap is starting to look less like an oversight and more like the industry’s most stubborn failure.
The Compliance Problem Nobody Talks About
The supplement industry measures success in sales figures. It does not measure how many of those bottles are actually finished.
There is a well-documented phenomenon in pharmaceutical and supplement research called non-adherence, the gap between what patients are prescribed or recommended and what they actually take. In pharmaceuticals, non-adherence contributes to preventable disease progression and significant healthcare costs. In supplements, the numbers are harder to track, but the clinical picture suggests a similar behavioral gap.
Doctors who counsel patients on nutritional deficiencies hear a consistent pattern. The patient starts a supplement. They take it for a week, maybe two. Then something interrupts the habit. The pills are inconvenient to carry. They cause nausea on an empty stomach. They’re large and uncomfortable to swallow. Or the patient simply forgets, because fitting a daily pill into a modern routine is more friction than it sounds.
The industry’s response to this problem has largely been to make the products more appealing from the outside: better packaging, subscription models, reminder apps. The delivery mechanism itself has remained unchanged.
Gummies Were Supposed to Solve This
About fifteen years ago, the supplement industry found what it thought was its answer to the compliance problem. Gummies were easier to take than pills. They tasted good. They removed the psychological barrier of swallowing a tablet. Sales took off, and the format rapidly became one of the fastest-growing categories in the supplement space.
The problem is that gummies introduced a new set of trade-offs that the industry was slow to fully address.
To create a chewable gummy with the right texture and shelf stability, manufacturers often rely on sugar-based and gelatin-based systems that influence nutritional density and formulation constraints. A person taking a daily multivitamin gummy may be consuming added sugars as part of their supplementation routine. This has drawn attention from health professionals, particularly in pediatric nutrition discussions, where the line between supplement and confectionery can become blurred.
There is also the issue of formulation limits. The gummy format restricts how much active ingredient can be included without affecting taste and texture, which can influence how products are designed and labeled. As a result, gummies are often optimized for palatability and convenience rather than maximum nutrient load.
Gummies solved a compliance problem by creating a palatability solution. They did not fully resolve the deeper engineering question, which is: what format delivers nutrients in a way that balances consistency, usability, and real-world adherence?
What Doctors See That Marketers Don’t
A clinician working in primary care or a specialty practice sees a different version of the supplement story than the one told in advertising.
They see the patient who was recommended iron supplementation after a blood panel revealed deficiency, and who comes back three months later still deficient, not necessarily because the supplement is ineffective, but because adherence never fully stabilizes. They see the elderly patient for whom swallowing has become genuinely difficult, for whom even a standard-sized capsule represents a real physical challenge. They see the post-surgical patient who cannot take anything solid. They see children who are old enough to need supplementation but too young for the habit-building process of daily supplementation to reliably stick.
The clinical reality is that a supplement that sits in a cabinet is worth exactly nothing. And yet the conversation about supplement efficacy often focuses more on formulation than on real-world use. Research frequently evaluates whether a nutrient has a biological effect, but less often captures how consistently it is actually taken outside controlled environments.
This is the clinical gap. The format creates a barrier that science alone does not always account for.
The Question Nobody Was Asking
For Dr. Dharmdev Joshi, a physician and orthopedic surgical assistant with eight years of clinical practice, the supplement compliance problem was not a market insight. It was a daily reality.
He had recommended supplements to patients hundreds of times. He had watched the same patterns repeat. He had seen patients who were motivated, educated, and genuinely committed to their health still struggle to maintain a supplement routine because the delivery format created friction that compounded over time.
The question he eventually found himself asking was not a medical question. It was a design question. If you started from scratch, with no assumption that a supplement had to come in pill or gummy form, what format would you actually build?
The answer, he came to believe, was not about finding a better pill. It was about asking whether the pill format itself was the problem.
Oral Thin Film: A Format Already Proven Elsewhere
The technology that underpins MedHugs, the company Dr. Joshi founded, is not new. Oral thin film strips have been used in pharmaceutical delivery for decades.
Medications in strip form have been developed in various therapeutic areas because the format offers practical advantages in ease of use and portability. Oral thin films dissolve on or under the tongue, removing the need for water and offering an alternative to traditional oral solid dosage forms. This makes them particularly useful in situations where swallowing tablets is difficult or inconvenient.
What had not been done at scale in the direct-to-consumer wellness space was applying this delivery format specifically to nutritional supplementation, developing a product line around it, and exploring how different nutrients could be formulated for this type of delivery system. That is what MedHugs is attempting to do.
The Pivot That Changes the Question
The conventional supplement company starts with a market gap: a deficiency that is common, an ingredient that is trending, a demographic that is underserved, and then builds a product to fill it. The format is often a secondary consideration, driven by manufacturing cost and consumer familiarity.
Dr. Joshi came at it from the opposite direction. The format question came first. If compliance is the root challenge, and if format plays a major role in usability, then format becomes a primary design constraint. The formulation follows.
This inversion matters because it changes what the product is optimized for. A supplement optimized for the shelf is designed for purchase. A supplement optimized for delivery is designed for consistent use.
What This Means for the Industry
MedHugs is not the first company to work with oral thin film technology, and it will not be the last. But its entry into the supplement space as a physician-founded operation reflects a broader shift in how the industry is thinking about delivery systems.
As consumer awareness of supplement quality continues to grow, and as discussions around adherence and usability become more central, the question of how supplements are delivered is becoming increasingly relevant.
The industry has spent decades refining what goes into capsules. The next phase of innovation is increasingly focused on whether the capsule remains the most effective format at all.
That question is already being explored. The answers are still evolving.
Award Winning Innovation In Modern Supplement Delivery
MedHugs has been recognized as the Best Oral Thin Film Vitamin Brand in the United States of 2026 by Evergreen Awards, a distinction that highlights the company’s physician founded approach to making daily supplementation more accessible, convenient, and consistent.
About MedHugs
MedHugs is a U.S.-based wellness startup founded by physician and entrepreneur Dr. Dharmdev Joshi, developing fast-dissolving oral thin film vitamin strips as an alternative to pills, capsules, and gummies to make daily supplementation more convenient and easier to maintain, especially for those who struggle with swallowing or consistency; more information is available at their official website, while sharing updates on social media platforms including Instagram, Facebook, Tiktok and LinkedIn.
Disclaimer: This article is for informational purposes only and should not be considered medical, pharmaceutical, or professional healthcare advice. Any statements about supplements, vitamins, or delivery formats reflect general discussion and should not be interpreted as verified clinical claims, guarantees, or recommendations for treatment. Readers should consult a qualified healthcare professional before making any health-related decisions, and any mention of companies, products, or individuals is for context only and does not imply endorsement or proven effectiveness.
